Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05827510 · ClinicalTrials.gov registry record · NA
Fractional Radiofrequency for Treatment of Acne Scars and Wrinkles
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05827510 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 31 participants.
The verdict
NCT05827510, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy, safety and the performance of the fractional radiofrequency delivered by the BTL-585-4 applicator of the BTL-585F system for non-invasive treatment of acne scars and facial wrinkles. The study is a prospective multicenter open label two-arm study. The subjects will be enrolled and assigned into two study groups, according to their indication; group A (acne scars) and B (facial wrinkles), each study group will receive treatment of different conditions. Subjects of both groups will be required to complete three (3) treatment visits and two to three follow-up visits.
Interventions
- DEVICE BTL-585F
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05827510
The ClinicalTrials.gov registry entry for NCT05827510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-585F is the first listed.
NCT05827510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05827510 about?
NCT05827510 is a clinical study titled "Fractional Radiofrequency for Treatment of Acne Scars and Wrinkles". This study will evaluate the clinical efficacy, safety and the performance of the fractional radiofrequency delivered by the BTL-585-4 applicator of the BTL-585F system for non-invasive treatment of acne scars and facial wrinkles. The study is a prospective multicenter open label two-arm study. The ...
What is the current status of trial NCT05827510?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-11-30. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT05827510?
The interventions under investigation include: BTL-585F (DEVICE).
Who is sponsoring clinical trial NCT05827510?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.